Delivery Order SPE2DE21D7001-SPE2D625F2KDD
- Not listed
- Medtronic Inc., through its Medtronic USA division, was awarded a delivery order valued at $9,753.65 on July 31, 2025, for the supply of Biologics—Synthetics MasterGraft Strip, a specialized medical product. The contract is a fixed-price agreement with economic price adjustment provisions and will be performed in Fridley, Minnesota, with an ultimate completion date of August 7, 2025. This delivery order was awarded without set-aside designation through the Defense Health Agency's Medical...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $3,507.40 by the Defense Health Agency's Medical Supply Chain division for Biologics - Synthetics MasterGraft Strip on July 18, 2025. The contract employs a fixed-price with economic price adjustment pricing model and carries no set-aside designation, reflecting the vendor's competitive capabilities in federal procurement. Performance will be executed in Fridley, Minnesota, with an ultimate...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $4,240.80 on July 24, 2025, by the Defense Health Agency's Medical Supply Chain for biologics identified as DBM-TS-GRAFTON DBF. This fixed-price delivery order with economic price adjustment provisions will be performed in Fridley, Minnesota and is scheduled for ultimate completion by July 25, 2025. The award was made without a set-aside designation through full and open competition, reflecting...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $2,875.65 by the Defense Health Agency's Medical Supply Chain on August 7, 2025, for biologics identified as DBM-TS-OTI Grafton DBM Matrix. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and carries an ultimate completion date of August 11, 2025. Performance will be executed in Fridley, Minnesota. This delivery order was not issued under any small...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order contract valued at $1,742.30 for biologics designated as DBM-TS-OTI Grafton Plus DBM on August 11, 2025. This fixed-price contract with economic price adjustment provisions is being performed in Fridley, Minnesota and was funded by the Defense Health Agency's Medical Supply Chain. The award utilized full and open competition with no set-aside designation, reflecting Medtronic's established competitive standing...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order contract valued at $4,260.75 by the Medical Supply Chain division of the Department of Defense on July 25, 2025, with an ultimate completion date of July 29, 2025. The contract, designated as GRAFTON INJECT (Contract Number 4568896282), is structured as a fixed-price delivery order with economic price adjustment provisions and will be performed in Fridley, Minnesota. This award was made without set-aside...
- Medtronic USA Inc. was awarded a fixed-price delivery order valued at $22,810.00 by the Medical Supply Chain division of the Defense Logistics Agency on August 4, 2025, with an ultimate completion date of August 7, 2025. This delivery order, designated as a contract type under the larger federal procurement framework, includes economic price adjustment provisions and carries no set-aside designation. The work will be performed in Fridley, Minnesota, where Medtronic maintains operations as a...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $1,791.40 by the Defense Health Agency's Medical Supply Chain on July 24, 2025, with an ultimate completion date of July 28, 2025. This fixed-price contract with economic price adjustment carries no set-aside designation and will be performed in Fridley, Minnesota. As a critical supplier of specialized medical devices to federal healthcare agencies, Medtronic is leveraging its established...
- Medtronic Inc., through its Medtronic USA, Inc. division, was awarded a delivery order valued at $5,374.20 on August 22, 2025, by the Defense Health Agency's Medical Supply Chain organization. This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 26, 2025, and will be performed in Fridley, Minnesota. The award represents a task order against Medtronic's existing contracting vehicle with the Defense Health Agency and aligns with the company's...
- This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA) to Medtronic Inc., a global medical technology company, for the procurement of "BIOLOGICS - SYNTHETICS-MASTERGRAFT STRIP" medical supplies. The contract has an ultimate completion date of October 29, 2024 and a ceiling value of $5,629.70. The contract is not set-aside and is a Fixed Price with Economic Price Adjustment type. Medtronic's Medtronic USA, Inc. division is the prime contractor on this...
- SPE2DE21D7001Indefinite Delivery Contract
- SPE2DE21D7001-SPE2D625F2KDDDelivery Order
Medtronic Inc.'s Medtronic USA division was awarded a delivery order on August 20, 2025, for biologics and synthetic products, specifically Mastergraft Strip, with a ceiling value of $5,367.50. This fixed-price contract with economic price adjustment has a completion date of September 5, 2025, and will be performed in Fridley, Minnesota. The contract was awarded without a set-aside designation through the Defense Health Agency's Medical Supply Chain, reflecting the agency's need for specialized biomaterial products to support defense healthcare operations and veteran medical services. Medtronic Inc. is a global medical technology leader headquartered in Minneapolis that serves as a critical supplier of advanced medical devices to federal healthcare agencies, particularly the Department of Veterans Affairs and the Defense Health Agency. This delivery order represents part of Medtronic's broader federal contract portfolio, which includes a $600 million indefinite delivery contract with the VA for surgical implants and related products through December 2028, along with specialized maintenance contracts for the company's proprietary medical navigation systems. The award of this relatively modest delivery order underscores Medtronic's established competitive position in providing specialized medical technologies and biomaterial solutions to federal defense and veteran healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/20/25 |